Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 89 peer-reviewed journal articles Updated
Clinical Immunology

Combined immunodeficiency due to ITK deficiency: A Patient Guide

At a Glance

ITK deficiency is a rare inherited immune disorder that weakens T-cell defenses, especially against EBV. Care focuses on close viral and laboratory monitoring, infection prevention, antibody support, and considering stem cell transplantation as a potentially curative treatment.

Safety Note: Combined immunodeficiency due to ITK deficiency is extremely rare, and evidence often relies on small case series. Care must be highly individualized. Always follow your treating immunology and transplant team’s written emergency plan rather than any numeric rules in this guide.

Combined immunodeficiency due to ITK deficiency is a rare, inherited condition that fundamentally changes how the immune system communicates. In a healthy child, white blood cells called T-cells act as specialized scouts and soldiers that identify and destroy viruses. For children with ITK deficiency, a genetic mutation alters a protein called the ITK kinase, which serves as a vital signal-booster within these cells [1][2]. Without this functioning protein, the T-cells remain “quiet” or impaired to certain threats, often preventing the immune system from mounting an effective defense against common germs [3][4].

The hallmark of this condition is an extreme vulnerability to the Epstein-Barr Virus (EBV), a virus that can cause infectious mononucleosis and is carried by most people. Because the immune system cannot properly regulate EBV, the virus can trigger the uncontrolled growth of white blood cells, leading to severe complications [5][6]. This can manifest as life-threatening inflammation known as Hemophagocytic Lymphohistiocytosis (HLH) or the development of lymphoma [7][8]. Understanding this risk is central to your child’s care, as it explains why doctors focus so intently on viral monitoring and the prevention of hyperinflammation [9].

Living with ITK deficiency requires a shift toward proactive, long-term medical management. This begins with a dedicated care team of immunologists and transplant specialists who provide supportive therapies, such as antibody replacements and protective medications, to reduce the risk of infection [10][11]. While the diagnosis is serious, modern medicine offers a potentially curative path forward through Hematopoietic Stem Cell Transplantation (HSCT). This procedure aims to replace the faulty immune system with healthy donor cells, offering the hope for a future where your child’s immune system can protect them as it should, though it carries its own significant risks that must be individualized [6][8].

As you navigate this journey, remember that you are not just a witness to your child’s care, but their most important advocate. The medical team is there to partner with you, providing the expertise and surveillance needed to keep your child safe while working toward the goal of a functional, healthy immune system. By staying informed and connected with specialists who understand this rare condition, you are providing your child with the best possible foundation for treatment and recovery [12][13].

In this guide

7 chapters

01

Understanding Your Child's ITK Deficiency Diagnosis

Learn what ITK deficiency means for your child, how it affects T-cells and EBV control, how it is inherited, and how doctors monitor serious complications.

02

The Biology of ITK Deficiency and Its Look-Alikes

Learn how ITK deficiency affects T-cell signaling, EBV risk, and diagnostic genetic testing, including differences from XLP1, XIAP, CD27, and CD70 deficiencies.

03

Symptoms, Complications, and Warning Signs

Learn the symptoms, EBV complications, and emergency warning signs of ITK deficiency in children, including HLH, fever, swelling, and unusual bleeding.

04

Your Child's Diagnostic Workup and Lab Reports

Learn how ITK deficiency is diagnosed in children, including genetic testing, flow cytometry, T-cell function assays, antibody levels, and EBV monitoring.

05

Standard of Care and Treatment Options

Learn how ITK deficiency is treated with infection prophylaxis, HLH and EBV control, and hematopoietic stem cell transplant, including recovery and risks.

06

Building Your Care Team and Preparing for Visits

Learn how to build an ITK deficiency care team, prepare your child’s specialist visits, organize records, and choose a center experienced in transplant care.

07

The Journey Forward: Post-Transplant Survivorship

Learn how children with ITK deficiency are monitored after HSCT, including EBV testing, donor chimerism, immune recovery, IVIG, vaccines, and late complications.

Common questions in this guide

What is combined immunodeficiency due to ITK deficiency?
It is a rare inherited disorder that disrupts signaling in T cells, making it harder for a child's immune system to control infections. Children are especially vulnerable to Epstein-Barr virus, which can cause serious complications.
Why can Epstein-Barr virus be dangerous for a child with ITK deficiency?
The immune system may not control Epstein-Barr virus normally, allowing infected white blood cells to grow abnormally. This can contribute to severe inflammation called hemophagocytic lymphohistiocytosis, or HLH, and may increase the risk of lymphoma.
How is a child with ITK deficiency monitored?
The care team may use regular Epstein-Barr virus viral-load testing and laboratory checks to look for infection, inflammation, or early signs of complications. The timing and exact tests should be individualized by the child's immunology and transplant specialists.
What treatments are used for ITK deficiency?
Supportive care can include antibody replacement and protective medicines to reduce infection risk. Hematopoietic stem cell transplantation replaces the faulty immune system with healthy donor cells and may offer a potentially curative treatment, but it has significant risks that require individualized discussion.
What precautions can help protect a child with ITK deficiency from infections?
Families should follow the written emergency and infection-prevention plan from the child's medical team, including recommended medicines and guidance for home and school. Contact the care team promptly when the child has possible infection or other concerning changes rather than relying on general numeric rules.
Can stem cell transplantation cure ITK deficiency?
Hematopoietic stem cell transplantation aims to rebuild the immune system with healthy donor cells and can be potentially curative. Whether and when to pursue it depends on the child's health, donor options, infection history, and the transplant team's assessment of benefits and risks.

Get notified when new evidence is published on Combined immunodeficiency due to ITK deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.

    Lechner KS, Neurath MF, Weigmann B

    Journal of molecular medicine (Berlin, Germany) 2020; (98(10)):1385-1395 doi:10.1007/s00109-020-01958-z.

    PMID: 32808093
  2. 2

    Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response.

    Andreotti AH, Joseph RE, Conley JM, et al.

    Annual review of immunology 2018; (36()):549-578 doi:10.1146/annurev-immunol-042617-053344.

    PMID: 29677469
  3. 3

    Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.

    Howe MK, Dowdell K, Roy A, et al.

    Frontiers in immunology 2019; (10()):2000 doi:10.3389/fimmu.2019.02000.

    PMID: 31507602
  4. 4

    Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.

    Eken A, Cansever M, Somekh I, et al.

    Journal of clinical immunology 2019; (39(4)):391-400 doi:10.1007/s10875-019-00632-5.

    PMID: 31025232
  5. 5

    Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.

    Latour S, Fischer A

    Immunological reviews 2019; (291(1)):174-189 doi:10.1111/imr.12791.

    PMID: 31402499
  6. 6

    Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?

    Ghosh S, Drexler I, Bhatia S, et al.

    Frontiers in immunology 2018; (9()):979 doi:10.3389/fimmu.2018.00979.

    PMID: 29867957
  7. 7

    Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.

    Kapnick SM, Stinchcombe JC, Griffiths GM, Schwartzberg PL

    Journal of immunology (Baltimore, Md. : 1950) 2017; (198(7)):2699-2711 doi:10.4049/jimmunol.1601202.

    PMID: 28213500
  8. 8

    Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.

    Alme C, Satwani P, Alobeid B, et al.

    Journal of pediatric hematology/oncology 2015; (37(7)):507-8 doi:10.1097/MPH.0000000000000366.

    PMID: 26056787
  9. 9

    Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.

    Marzolini MAV, Wilson AJ, Sanchez E, et al.

    Transplantation and cellular therapy 2021; (27(8)):682.e1-682.e12 doi:10.1016/j.jtct.2021.04.020.

    PMID: 33962069
  10. 10

    An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.

    Sahin U, Toprak SK, Atilla PA, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016; (22(8)):505-14.

    PMID: 27344206
  11. 11

    Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.

    Alsina L, Celis Passini V, Garrido Colino C, et al.

    Leukemia & lymphoma 2026; (67(11)):2192-2205 doi:10.1080/10428194.2026.2704265.

    PMID: 42518275
  12. 12

    Epstein-Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge.

    Barman P, Basu S, Goyal T, et al.

    Expert review of clinical immunology 2024; (20(11)):1331-1346 doi:10.1080/1744666X.2024.2386427.

    PMID: 39066572
  13. 13

    Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

    Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD

    Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.

    PMID: 31440487

This page provides general information about ITK deficiency and does not constitute medical advice. Because the condition is rare and treatment risks vary, follow your child's immunology and transplant team's individualized plan.